IB Acquisition Corp. SEC filings IBAC
IB Acquisition Corp. has 90 filings in SEC EDGAR's recent list, going back to Nov 17, 2023. Its latest annual report, Form ARS, was filed on Nov 4, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Nov 4, 2026 | Sep 30, 2025 |
| DEF 14A | Proxy statement | Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Other events
|
Oct 15, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 6, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 30, 2026 | Sep 24, 2026 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale
|
Sep 23, 2026 | Sep 15, 2026 |
| 425 | Filing | Sep 23, 2026 | — |
| 425 | Filing | Sep 23, 2026 | — |
| 425 | Filing | Sep 21, 2026 | — |
| 8-K |
Current report
Material agreement
|
Sep 21, 2026 | Sep 15, 2026 |
| DEF 14A | Proxy statement | Sep 4, 2026 | Sep 4, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 25, 2026 | Aug 24, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| S-4 | Registration for a merger or exchange | Jul 24, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 425 | Filing | Apr 17, 2026 | — |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Mar 27, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Mar 26, 2026 | Mar 25, 2026 |
| 425 | Filing | Mar 18, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 18, 2026 | Mar 13, 2026 |
| 425 | Filing | Mar 16, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 16, 2026 | Mar 16, 2026 |
| DEF 14A | Proxy statement | Feb 23, 2026 | Feb 23, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 12, 2026 | Feb 12, 2026 |
| 10-Q | Quarterly report | Feb 11, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Dec 29, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results
|
Sep 24, 2025 | Sep 22, 2025 |
| DEFR14A | Filing | Sep 10, 2025 | — |
| DEF 14A | Proxy statement | Sep 10, 2025 | Sep 9, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 29, 2025 | Aug 29, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Feb 13, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Dec 26, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K/A |
Amended current report
Auditor change
|
May 13, 2024 | Apr 22, 2024 |
| 25-NSE | Delisting notice | Apr 30, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 26, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 26, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Other events
|
Apr 3, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Mar 29, 2024 | Mar 29, 2024 |
| 424B4 | Prospectus | Mar 27, 2024 | — |
| EFFECT | Filing | Mar 25, 2024 | — |
| CERT | Filing | Mar 22, 2024 | — |
| CORRESP | Letter to the SEC | Mar 21, 2024 | — |
| CORRESP | Letter to the SEC | Mar 21, 2024 | — |
| 8-A12B | Filing | Mar 21, 2024 | — |
| CORRESP | Letter to the SEC | Mar 21, 2024 | — |
| S-1/A | Amended registration statement | Mar 8, 2024 | — |
| CORRESP | Letter to the SEC | Mar 8, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2024 | — |
| S-1/A | Amended registration statement | Jan 31, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2024 | — |
| CORRESP | Letter to the SEC | Dec 19, 2023 | — |
| S-1/A | Amended registration statement | Dec 19, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2023 | — |
| S-1 | Registration statement | Nov 17, 2023 | — |
Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- IBAC (Nasdaq), IBACR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Boca Raton, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1998781
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.